Living donor liver transplantation for myocerebrohepatopathy spectrum due to POLG mutations
Pediatric Transplantation · 2024
DOI: 10.1111/petr.14659 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Masashi Kadohisa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Failure, Acute. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
POLG is one of several nuclear genes associated with mitochondrial DNA maintenance defects and is a group of diseases caused by mitochondrial DNA deficiency that results in impaired adenosine triphosphate production and organ dysfunction. Myocerebrohepatopathy spectrum (MCHS) is the most severe and earliest presentation of POLG mutations, and liver transplantation (LT) for MCHS has never been reported. Case presentation The patient was a 3‐month‐old boy with acute liver failure and no neurological manifestations (e.g., seizures). We performed a living donor LT using a left lateral segment graft from his father. The postoperative course was uneventful. Subsequently, a homozygous POLG mutation (c.2890C>T, p. R964C) was identified by multigene analysis of neonatal/infantile intrahepatic cholestasis. Moreover, respiratory chain complex I, II, and III enzyme activities and the ratio of mtDNA to nuclear DNA in the liver were reduced. Therefore, we considered that these clinical manifestations and examination findings met the definition for MCHS. During meticulous follow‐up, the patient had shown satisfactory physical growth and mental development until the time of writing this report.
Conclusion
We presumed that the absence of remarkable neurologic manifestations prior to LT in patients with MCHS is a good indication for LT and contributes to a better prognosis in the present case.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- Department of Pediatric Surgery, Kyoto University Hospital, Kyoto, Japan.
- Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
- Department of Child Health, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
- Department of Metabolism, Center for Medical Genetics, Chiba Children's Hospital, Chiba, Japan.
ORCID-Profile: Masashi Kadohisa, Tatsuya Okamoto
Zitieren
APA
Kadohisa, M., Okamoto, T., Yamamoto, M., Uebayashi, E. Y., Sonoda, M., Ogawa, E., Yokoyama, A., Kawasaki, H., Hiejima, E., Ito, S., Togawa, T., Imagawa, K., Murayama, K., Okajima, H., & Hatano, E. (2024). Living donor liver transplantation for myocerebrohepatopathy spectrum due to POLG mutations. Pediatric Transplantation. https://doi.org/10.1111/petr.14659
Vancouver
Kadohisa M, Okamoto T, Yamamoto M, Uebayashi EY, Sonoda M, Ogawa E, et al. Living donor liver transplantation for myocerebrohepatopathy spectrum due to POLG mutations. Pediatric Transplantation. 2024. doi:10.1111/petr.14659
BibTeX
@article{Kadohisa2024,
author = {Kadohisa, Masashi and Okamoto, Tatsuya and Yamamoto, Miki and Uebayashi, Elena Yukie and Sonoda, Mari and Ogawa, Eri and Yokoyama, Atsushi and Kawasaki, Hidenori and Hiejima, Eitaro and Ito, Shogo and Togawa, Takao and Imagawa, Kazuo and Murayama, Kei and Okajima, Hideaki and Hatano, Etsuro},
title = {Living donor liver transplantation for myocerebrohepatopathy spectrum due to POLG mutations},
journal = {Pediatric Transplantation},
year = {2024},
doi = {10.1111/petr.14659}
}
EUVIMED